University of North Texas   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Denton TX United States (1890)

Organization Overview

First Clinical Trial
2002
NCT00227123
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

University of North Texas, Denton, TX | University of North Texas Health Science Center | UNTHSC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 3)

Cognitive Dysfunction (Phase 4)

Communicable Diseases (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Helicobacter Infections (Phase 3)

Infections (Phase 3)

Stroke (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 12